Bone-resorbing osteoclasts develop from monocyte-macrophage lineage cells under the regulation of boneforming osteoblasts. Osteoblasts express two cytokines essential for osteoclastogenesis, macrophage colonystimulating factor (M-CSF) and receptor activator of nuclear factor-B ligand (RANKL). Osteoblasts also produce osteoprotegerin (OPG), a decoy receptor for RANKL, which inhibits the interaction between RANKL and RANK, a receptor of RANKL. Wnt proteins (Wnts) play a central role in the development of organs and tissues. There are two pathways of Wnt signaling. -catenin-dependent canonical and -catenin-independent noncanonical pathways. The discovery that loss-of-function mutations in low density lipoprotein receptorrelated protein 5 (LRP5), a Wnt co-receptor, led to low bone mass in humans revealed the possible role of Wnt signaling in bone formation: Wnts act on osteoblast precursor cells and promote their differentiation into osteoblasts through the -catenin-dependent canonical pathway. In addition, Wnts suppress bone resorption by the up-regulation of OPG expression and the down-regulation of RANKL expression in osteoblasts through the same pathway. In contrast, the activation of the -catenin-independent noncanonical pathway enhances the RANKL-induced osteoclastogenesis. Recent studies have shown that the -catenin independent noncanonical pathway is also involved in bone resorption induced by arthritis. This review summarizes the regulatory mechanism of bone resorption by Wnt signals.
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